Gujarat Themis Biosyn Ltd vs Sunrest Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 14, 2026

Key Highlights

The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 376.15 as of 14 May 15:30 . The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 9.8 on March 2021 to 62.8 on March 2025 . This represents a CAGR of 44.99% over 5 yearsThe P/E Ratio of Sunrest Lifescience Ltd changed from 115.2 on March 2024 to 11.5 on March 2025 . This represents a CAGR of -68.40% over 2 years The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 295.88 crore on March 2021 to ₹ 3067 crore on March 2025 . This represents a CAGR of 59.64% over 5 yearsThe Market Cap of Sunrest Lifescience Ltd changed from ₹ 26.2 crore on March 2024 to ₹ 23.07 crore on March 2025 . This represents a CAGR of -6.16% over 2 years The revenue of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 43.78 crore as compare to the Sep '25 revenue of ₹ 43.17 crore. This represent the growth of 1.41% The revenue of Sunrest Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gujarat Themis Biosyn Ltd for the Dec '25 is ₹ 21.72 crore as compare to the Sep '25 ebitda of ₹ 21.76 crore. This represent the decline of -0.18% The ebitda of Sunrest Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 13.24 crore to ₹ 12.46 crore over 7 quarters. This represents a CAGR of -3.41% The net profit of Sunrest Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 36.62 % on March 2022 to 14.97 % on March 2025 . This represents a CAGR of -20.04% over 4 yearsThe Dividend Payout of Sunrest Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Gujarat Themis Biosyn Ltd

Promoted byJayshree D Patel, Gujarat Themis Biosyn Limited (GTBL) was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Sunrest Lifescience Ltd

Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market.
The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan.
It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste.
Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Sunrest Lifescience Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 4,113 Cr while Market cap of Sunrest Lifescience Ltd is 32 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd?

As of May 14, 2026, the Gujarat Themis Biosyn Ltd stock price is INR ₹377.5. On the other hand, Sunrest Lifescience Ltd stock price is INR ₹38.0.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Sunrest Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.